Guyer Charles Greg 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Nov 14, 2024
Insider Transaction Report
Form 4
Guyer Charles Greg
EVP, Chief Technical Officer
Transactions
- Award
Common Stock
2024-10-31$56.01/sh+55$3,080→ 74,187 total - Sale
Common Stock
2024-11-12$66.37/sh−5,278$350,324→ 68,909 total
Footnotes (2)
- [F1]Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan.
- [F2]The price in column 4 is the weighted average price. The purchase price actually received ranged from $66.37 to $66.395. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.